Chemical Compound
5001B; Antibiotic 5001B; Antibiotic 56-62; Antibiotic A 164AB; Azalomycin B; Efomycin E; Efomycine E; Gopalamicin; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; 1,9-Dioxacyclohexadecane, elaiophylin deriv.; (+)-Elaiophylin
CAS Registry Number
37318-06-2
Primary record
5001B; Antibiotic 5001B; Antibiotic 56-62; Antibiotic A 164AB; Azalomycin B; Efomycin E; Efomycine E; Gopalamicin; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; 1,9-Dioxacyclohexadecane, elaiophylin deriv.; (+)-Elaiophylin
- 库存
- 5,809 克
- 纯度
- 98.4 %
- CAS
- 37318-06-2
化合物标识与属性
- CAS
- 37318-06-2
- PubChem CID
- 6444206
- SMILES
- CC[C@H]1[C@@H](C[C@](O[C@@H]1C)(O)[C@H]([C@H](O)[C@@H]([C@H]2OC(=O)/C=C/C=C/[C@@H]([C@H](OC(=O)/C=C/C=C/[C@@H]2C)[C@H]([C@@H](O)[C@@H]([C@@]3(O[C@@H]([C@H]([C@@H](C3)O[C@@H]4O[C@H]([C@H]([C@H](C4)O)O)C)CC)C)O)C)C)C)C)C)O[C@@H]5O[C@H]([C@H]([C@H](C5)O)O)C
- Canonical SMILES
- CC[C@@H]1[C@@H](C)O[C@@](O)([C@@H](C)[C@H](O)[C@H](C)[C@H]2OC(=O)/C=C/C=C/[C@H](C)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]3(O)C[C@@H](O[C@H]4C[C@H](O)[C@H](O)[C@H](C)O4)[C@H](CC)[C@@H](C)O3)OC(=O)/C=C/C=C/[C@@H]2C)C[C@H]1O[C@H]1C[C@H](O)[C@H](O)[C@H](C)O1
名称与同义词
- Elaiophylin
- Azalomycin B
- Gopalamicin
- Azalomycin-B
- Salbomycin
- Antibiotic 5001B
- Antibiotic 56-62
- Elaiofilin
- Elayofilin
- Azalomycin F
- Efomycin E
- Azalomycin-B/
- 37318-06-2
- EFOMYCINE E
- Elaiophylin (>85%)
- (+)-ELAIOPHYLIN
- RefChem:136444
- 1CAF8865TM
- UNII-1CAF8865TM
- AC1O60GL
- ANTIBIOTIC A-164AB
- CHEBI:77879
- DTXSID001318254
- orb1685615
- SCHEMBL1231934
- CHEMBL3740707
- DTXCID301748040
- EX-A3078
- 2393AH
- ABP000608
- BBF-01780
- C54H88O13
- C54H88O18
- HB0273
- MFCD01939399
- 5001B
- AKOS032945123
- AT33746
- CID6444206
- SNA 4606-3
- C54-H88-O13
- AC-35864
- HY-15184
- LS-22686
- B2138
- CS-0003802
- A874133
- Q27147492
- Azalomycin-B, Gopalamicin, SNA 4606-3, 37318-06-2
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis((2S,3R,4S)-4-((2R,4R,5R,6R)-4-(((2R,4S,5S,6S)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-ethyl-2-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)-3-hydroxypentan-2-yl)-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis[(2S,3R,4S)-4-[(2R,4R,5R,6R)-4-[(2R,4S,5S,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-5-ethyl-2-hydroxy-6-methyloxan-2-yl]-3-hydroxypentan-2-yl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis((2S,3R,4S)-4-((2R,4R,5R,6R)-4-(((2R,4S,5S,6S)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-5-ethyl-2-hydroxy-6-methyltetrahydro-2H-pyran-2-yl
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis((2S,3R,4S)-4-((2R,4R,5R,6R)-4-((2R,4S,5S,6S)-4,5-dihydroxy-6-methyloxan-2-yl)oxy-5-ethyl-2-hydroxy-6-methyloxan-2-yl)-3-hydroxypentan-2-yl)-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis[(1S,2R,3S)-3-[(2R,4R,5R,6R)-4-[(2R,4S,5S,6S)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-5-ethyl-2-hydroxy-6-methyl-tetrahydropyran-2-yl]-2-hydroxy-1-methyl-butyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- (3E,5E,7S,8S,11E,13E,15S,16S)-8,16-bis{(2S,3R,4S)-4-[(2R,4R,5R,6R)-4-{[(2R,4S,5S,6S)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-5-ethyl-2-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]-3-hydroxypentan-2-yl}-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- (3E,5E,7S,8S,11E,13E,15S,16S)-8-{(2S,3R,4S)-4-[(2R,4R,5R,6R)-4-{[(2R,4S,5S,6S)-4,5-Dihydroxy-6-methyloxan-2-yl]oxy}-5-ethyl-2-hydroxy-6-methyloxan-2-yl]-3-hydroxypentan-2-yl}-16-{(3R,4S)-4-[(2R,4R,5R,6R)-4-{[(2R,4S,5S,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-5-ethyl-2-hydroxy-6-methyloxan-2-yl]-3-hydroxypentan-2-yl}-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- )-3-hydroxypentan-2-yl)-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione
- 5001B; Antibiotic 5001B; Antibiotic 56-62; Antibiotic A 164AB; Azalomycin B; Efomycin E; Efomycine E; Gopalamicin; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; [7S-[3E,5E,7R*,8R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)],11E,13E,15R*,16R*[1R*,2S*,3R*(2S*,4S*,5S*,6S*)]]]-8,16-Bis[3-[4-[(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-5-ethyltetrahydro-2-hydroxy-6-methyl-2H-pyran-2-yl]-2-hydroxy-1-methylbutyl]-7,15-dimethyl-1,9-dioxacyclohexadeca-3,5,11,13-tetraene-2,10-dione; 1,9-Dioxacyclohexadecane, elaiophylin deriv.; (+)-Elaiophylin
- ELO